Showing 1,277 results

Filters Content type: News, Editors' picks, About HIV Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

The search for a cure

Gene therapy snips HIV out of infected cells and makes uninfected cells resistant

News
30 March 2016
New & experimental HIV treatments

Combination inhibitor BMS-986197 demonstrates good activity against HIV in early study

News
18 March 2016
PrEP science

Maraviroc may work as PrEP in combination with another drug – but probably not by itself

News
3 March 2016
PrEP

San Francisco HIV providers: What did you learn at CROI 2016?

Editor's pick
BETA blog
3 March 2016
New & experimental HIV treatments

ABIVAX’s Novel Approach to Treat HIV Demonstrates Safety and Preliminary Anti-viral Activity in Phase IIa

Editor's pick
Abivax press release
2 March 2016
New & experimental HIV treatments

Gilead Sciences Announces FDA Approval of Odefsey as HIV-1 Treatment in Certain Patients

Editor's pick
Gilead press release
2 March 2016
The search for a cure

Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption

News
29 February 2016
New & experimental HIV treatments

European CHMP Adopts Positive Opinion for Gilead’s Fixed-Dose Combination Descovy® (Emtricitabine/Tenofovir Alafenamide) for the Treatment of HIV

Editor's pick
Gilead press release
26 February 2016
The search for a cure

Sangamo BioSciences Presents Phase 2 Immunological Data from SB-728-T ZFP Therapeutic® HIV Program at CROI 2016

Editor's pick
Sangamo Biosciences press release
26 February 2016
HIV treatment for children & young people

Dolutegravir safe and highly effective in older children

News
25 February 2016
New & experimental HIV treatments

TAF/emtricitabine maintains viral suppression as well as TDF regimens with less bone and kidney toxicity

News
25 February 2016
PrEP

What is a drug “tail,” and what does it have to do with long-acting PrEP?

Editor's pick
BETA blog
25 February 2016
New & experimental HIV treatments

Gilead announces results from first study to evaluate switching to FTAF-based regimens from Truvada® (FTDF)-based regimens

Editor's pick
Gilead press release
24 February 2016
New & experimental HIV treatments

Dose-finding trials of antibody-based drugs for HIV prevention will start soon

News
24 February 2016
New & experimental HIV treatments

Long-acting injectable cabotegravir + rilpivirine works well as HIV maintenance therapy

News
23 February 2016
New & experimental HIV treatments

Once-daily Isentress non-inferior to twice-daily dose

Editor's pick
Merck press release
22 February 2016
New & experimental HIV treatments

Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice

News
5 February 2016
The search for a cure

Adenosine deaminase may help the immune system fight HIV on its own

Editor's pick
Eurekalert Medicine & Health
3 February 2016
New & experimental HIV treatments

CytoDyn Announces HIV-Patients Approaching 17 Months of Complete Viral Suppression With PRO 140 Monotherapy

Editor's pick
Cytodyn Inc.
27 January 2016
New & experimental HIV treatments

Experimental Combination Surprises with Anti-HIV Effectiveness

Editor's pick
National Institute of Mental Health
27 January 2016
New & experimental HIV treatments

IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon

Editor's pick
TheBody Pro
21 January 2016
New & experimental HIV treatments

ABIVAX announces positive top-line clinical Phase IIa data for novel HIV drug-candidate ABX464

Editor's pick
Medical News Today
13 January 2016
New & experimental HIV treatments

Janssen, ViiV Healthcare Formalize Injectable Rilpivirine + Cabotegravir Phase 3 as HIV Treatment

Editor's pick
Street Insider
8 January 2016
New & experimental HIV treatments

HIV Antibody Infusion Safely Suppresses Virus in Infected People

Editor's pick
National Institute of Allergy and Infectious Diseases (NIAID)
24 December 2015